Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

Systemic Sclerosis

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Arthritis Res Ther

Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H

doi: 10.1186/s13075-025-03654-0

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Systemic Sclerosis

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

Rheumatology (Oxford)

Villar MJ, Di Donato S, Bozan MF, Manning J, Mandzuk M, Wragg E, Samaranayaka M, Murray A, Herrick AL, Dinsdale G, Hughes M

doi: 10.1093/rheumatology/keaf383

Systemic Sclerosis

Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

Arthritis Res Ther

Liakouli V, Forte G, Ruscitti P, Navarini L, Bellisai F, Caso F, Guggino G, La Barbera L, Rizzo C, Corrado A, Triggianese P, Lo Gullo A, Mandraffino G, Cantarini L, Frediani B, Cipriani P, Cantatore FP, Chimenti MS, Favoino E, Perosa F, Iagnocco A, Giacomelli R, Ciccia F

doi: 10.1186/s13075-025-03619-3

Systemic Lupus Erythematosus

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Arthritis Res Ther

Kojima K, Ichinose K, Umeda M, Shimizu T, Sato S, Suzuki T, Nakashima Y, Okada A, Horai Y, Fujikawa K, Aramaki T, Miyashita T, Furuyama M, Matsuoka N, Kawakami A

doi: 10.1186/s13075-025-03581-0

Systemic Lupus ErythematosusSystemic Sclerosis

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Rheumatology (Oxford)

Patasova K, Dehara M, Mantel Ä, Bixo M, Arkema E, Holmqvist M

doi: 10.1093/rheumatology/keaf004

Rheumatoid Arthritis

Infant-onset juvenile idiopathic arthritis - a multicenter retrospective study

Rheumatology (Oxford)

Strauss T, Klotsche J, Windschall D, Sprengel A, Krumrey-Langkammerer M, Dollinger S, Haas JP, Tenbrock K, Trauzeddel R, Girschick H, Heubner G, Oommen PT, Hufnagel M, Freudenhammer M, Dressler F, Raab A, Dückers G, Behrendes R, Klemann C, Jansson A, Horneff G, Klein A, Zimmer A, Hospach A, Kümmerle-Deschner J, Holl-Wieden A, Brück N, Minden K, Schuetz C, NPRD study group

doi: 10.1093/rheumatology/keaf586

Systemic Sclerosis

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Rheumatology (Oxford)

Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH

doi: 10.1093/rheumatology/keaf006

Systemic Sclerosis

Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study

Semin Arthritis Rheum

De Luca G, De Santis M, Batani V, Tonutti A, Campochiaro C, Palmisano A, Vignale D, Motta F, Monti L, Francone M, Selmi C, Matucci-Cerinic M, Esposito A, Dagna L

doi: 10.1016/j.semarthrit.2024.152622

Related content

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Infant-onset juvenile idiopathic arthritis - a multicenter retrospective study

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study